Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
117
days
Sirolimus Therapy and Dyslipidemia in Neonates and Infants: A Retrospective Cohort and Pharmacovigilance Analysis
Authors
Akinobu Taniguchi; Basile Chrétien; Takashi Maeda; Kazuto Ueda; Ryosuke Miura; Ryuichi Tanaka; Toshihiko Suzuki; Yukako Muramatsu; Yoshiaki Sato; Kazuki NishidaShow moreShow less
Affiliations
1. Division of Neonatology, Center for Maternal-Neonatal Care, Nagoya University Hospital, Nagoya, Japan; 2. Department of International Medical Education, Nagoya University, Nagoya, Japan; 3. Department of Biostatistics, Graduate School of Medicine, Nagoya University, Nagoya, Japan; 4. Department of Clinical Biostatistics, School of Public Health, Graduate School of Medicine, Kyoto University, Kyoto, JapanShow moreShow less
20
days
Copper Histidinate: Pediatric First Approval
Authors
Hannah A. BlairShow moreShow less
Affiliations
1. Springer Nature, Auckland, New ZealandShow moreShow less
108
days
Long-Term Safety and Efficacy of Dupilumab Treatment in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis
Authors
Amy S. Paller; Andreas Pinter; Lara Wine Lee; Roland Aschoff; Jacek Zdybski; Christina Schnopp; Faisal A. Khokhar; Amy H. Praestgaard; Ashish Bansal; Brad Shumel; Mike BastianShow moreShow less
Affiliations
1. Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, USA; 2. Division of Dermatology, Ann & Robert H. Lurie Children’s Hospital, Chicago, USA; 3. Department of Dermatology, University Hospital Frankfurt am Main, Frankfurt am Main, Germany; 4. Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, USA; 5. University Hospital Carl Gustav Carus, Dresden, Germany; 6. Klinika Zdybski Dermedic, Ostrowiec Świętokrzyski, Poland; 7. Department of Dermatology and Allergology, Technical University of Munich, Munich, Germany; 8. Regeneron Pharmaceuticals Inc., Tarrytown, USA; 9. Sanofi, Cambridge, USA; 10. Sanofi, Frankfurt, GermanyShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days